
Mary Mosher
Examiner (ID: 10578)
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1641, 1805, 2899, 1813, 1648, 1804, 1643, 1815, 1609 |
| Total Applications | 1434 |
| Issued Applications | 907 |
| Pending Applications | 126 |
| Abandoned Applications | 404 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4802632
[patent_doc_number] => 20080014220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-17
[patent_title] => 'Vaccine Against Hpv16 And Hpv18 And At Least Another Hpv Type Selected From Hpv 31, 45 Or 52'
[patent_app_type] => utility
[patent_app_number] => 11/570603
[patent_app_country] => US
[patent_app_date] => 2005-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12003
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20080014220.pdf
[firstpage_image] =>[orig_patent_app_number] => 11570603
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/570603 | Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52 | Jun 13, 2005 | Issued |
Array
(
[id] => 5520919
[patent_doc_number] => 20090028900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'WEST NILE VIRUSES WITH MUTATIONS IN THE 3\' TERMINAL STEM AND LOOP SECONDARY STRUCTURE FOR USE AS LIVE VIRUS VACCINES'
[patent_app_type] => utility
[patent_app_number] => 11/629560
[patent_app_country] => US
[patent_app_date] => 2005-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17830
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20090028900.pdf
[firstpage_image] =>[orig_patent_app_number] => 11629560
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/629560 | West Nile viruses with mutations in the 3′ terminal stem and loop secondary structure for use as live virus vaccines | Jun 13, 2005 | Issued |
Array
(
[id] => 5618986
[patent_doc_number] => 20060188519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Peptides, antibodies, and methods for the diagnosis of SARS'
[patent_app_type] => utility
[patent_app_number] => 11/152520
[patent_app_country] => US
[patent_app_date] => 2005-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14845
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20060188519.pdf
[firstpage_image] =>[orig_patent_app_number] => 11152520
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/152520 | Peptides, antibodies, and methods for the diagnosis of SARS | Jun 12, 2005 | Abandoned |
Array
(
[id] => 6380326
[patent_doc_number] => 20100316653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF ORTHOPOXVIRUSES'
[patent_app_type] => utility
[patent_app_number] => 11/629417
[patent_app_country] => US
[patent_app_date] => 2005-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 25723
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0316/20100316653.pdf
[firstpage_image] =>[orig_patent_app_number] => 11629417
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/629417 | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF ORTHOPOXVIRUSES | Jun 12, 2005 | Abandoned |
Array
(
[id] => 5502143
[patent_doc_number] => 20090162831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => ' HUMAN PARVOVIRUS'
[patent_app_type] => utility
[patent_app_number] => 11/569554
[patent_app_country] => US
[patent_app_date] => 2005-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 25980
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20090162831.pdf
[firstpage_image] =>[orig_patent_app_number] => 11569554
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/569554 | Human parvovirus | May 23, 2005 | Issued |
Array
(
[id] => 575932
[patent_doc_number] => 07452542
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-18
[patent_title] => 'Live attenuated coronavirus vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/135603
[patent_app_country] => US
[patent_app_date] => 2005-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13736
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/452/07452542.pdf
[firstpage_image] =>[orig_patent_app_number] => 11135603
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/135603 | Live attenuated coronavirus vaccines | May 22, 2005 | Issued |
Array
(
[id] => 337768
[patent_doc_number] => 07504109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-17
[patent_title] => 'Influenza hemagglutinin and neuraminidase variants'
[patent_app_type] => utility
[patent_app_number] => 11/133346
[patent_app_country] => US
[patent_app_date] => 2005-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 30907
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/504/07504109.pdf
[firstpage_image] =>[orig_patent_app_number] => 11133346
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/133346 | Influenza hemagglutinin and neuraminidase variants | May 19, 2005 | Issued |
Array
(
[id] => 5585024
[patent_doc_number] => 20090104226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Alphavirus Vectors for Respiratory Pathogen Vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/597347
[patent_app_country] => US
[patent_app_date] => 2005-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 35122
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20090104226.pdf
[firstpage_image] =>[orig_patent_app_number] => 11597347
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/597347 | Alphavirus Vectors for Respiratory Pathogen Vaccines | May 19, 2005 | Abandoned |
Array
(
[id] => 4778296
[patent_doc_number] => 20080286294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Nodavirus-Vlp Immunization Composition'
[patent_app_type] => utility
[patent_app_number] => 11/596860
[patent_app_country] => US
[patent_app_date] => 2005-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11846
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20080286294.pdf
[firstpage_image] =>[orig_patent_app_number] => 11596860
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/596860 | Nodavirus-Vlp Immunization Composition | May 18, 2005 | Abandoned |
Array
(
[id] => 5820357
[patent_doc_number] => 20060024670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Influenza virus vaccine composition and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/131479
[patent_app_country] => US
[patent_app_date] => 2005-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 61378
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024670.pdf
[firstpage_image] =>[orig_patent_app_number] => 11131479
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/131479 | Influenza virus vaccine composition and methods of use | May 17, 2005 | Abandoned |
Array
(
[id] => 337864
[patent_doc_number] => 07504205
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-17
[patent_title] => 'Uncharacterized ORF3 in SARS-coronavirus is a cyclic-AMP-dependent kinase and a target for SARS therapy'
[patent_app_type] => utility
[patent_app_number] => 11/132142
[patent_app_country] => US
[patent_app_date] => 2005-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 7981
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/504/07504205.pdf
[firstpage_image] =>[orig_patent_app_number] => 11132142
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/132142 | Uncharacterized ORF3 in SARS-coronavirus is a cyclic-AMP-dependent kinase and a target for SARS therapy | May 16, 2005 | Issued |
Array
(
[id] => 5258743
[patent_doc_number] => 20070212375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Process For Producing In Yeast Empty Viral Capsids Consisting Of Proteins Derived From Pvp2 Of The Infectious Bursal Disease Virus (Ibdv)'
[patent_app_type] => utility
[patent_app_number] => 10/576778
[patent_app_country] => US
[patent_app_date] => 2005-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6834
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20070212375.pdf
[firstpage_image] =>[orig_patent_app_number] => 10576778
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/576778 | Process For Producing In Yeast Empty Viral Capsids Consisting Of Proteins Derived From Pvp2 Of The Infectious Bursal Disease Virus (Ibdv) | Apr 26, 2005 | Abandoned |
Array
(
[id] => 6977445
[patent_doc_number] => 20050287161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Vaccine'
[patent_app_type] => utility
[patent_app_number] => 11/114301
[patent_app_country] => US
[patent_app_date] => 2005-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9183
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20050287161.pdf
[firstpage_image] =>[orig_patent_app_number] => 11114301
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/114301 | Vaccine | Apr 25, 2005 | Abandoned |
Array
(
[id] => 6977454
[patent_doc_number] => 20050287170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Subunit vaccine against West Nile viral infection'
[patent_app_type] => utility
[patent_app_number] => 11/114325
[patent_app_country] => US
[patent_app_date] => 2005-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18695
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20050287170.pdf
[firstpage_image] =>[orig_patent_app_number] => 11114325
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/114325 | Subunit vaccine against West Nile viral infection | Apr 24, 2005 | Abandoned |
Array
(
[id] => 7050335
[patent_doc_number] => 20050186222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Vaccines against West Nile Virus'
[patent_app_type] => utility
[patent_app_number] => 11/110517
[patent_app_country] => US
[patent_app_date] => 2005-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 14126
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20050186222.pdf
[firstpage_image] =>[orig_patent_app_number] => 11110517
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/110517 | Vaccines against West Nile Virus | Apr 19, 2005 | Issued |
Array
(
[id] => 7050335
[patent_doc_number] => 20050186222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Vaccines against West Nile Virus'
[patent_app_type] => utility
[patent_app_number] => 11/110517
[patent_app_country] => US
[patent_app_date] => 2005-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 14126
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20050186222.pdf
[firstpage_image] =>[orig_patent_app_number] => 11110517
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/110517 | Vaccines against West Nile Virus | Apr 19, 2005 | Issued |
Array
(
[id] => 150827
[patent_doc_number] => 07682618
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-23
[patent_title] => 'Generation of virus-like particles and use as panfilovirus vaccine'
[patent_app_type] => utility
[patent_app_number] => 11/105031
[patent_app_country] => US
[patent_app_date] => 2005-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 31
[patent_no_of_words] => 21496
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/682/07682618.pdf
[firstpage_image] =>[orig_patent_app_number] => 11105031
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/105031 | Generation of virus-like particles and use as panfilovirus vaccine | Apr 12, 2005 | Issued |
Array
(
[id] => 7184903
[patent_doc_number] => 20050191696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products'
[patent_app_type] => utility
[patent_app_number] => 11/104506
[patent_app_country] => US
[patent_app_date] => 2005-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 43105
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20050191696.pdf
[firstpage_image] =>[orig_patent_app_number] => 11104506
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/104506 | Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products | Apr 12, 2005 | Issued |
Array
(
[id] => 4733418
[patent_doc_number] => 20080050397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'MULTIPLE ANTIGENIC AGENTS AND METHODS FOR USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 11/093107
[patent_app_country] => US
[patent_app_date] => 2005-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9405
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20080050397.pdf
[firstpage_image] =>[orig_patent_app_number] => 11093107
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/093107 | Multiple antigenic agents and methods for using the same | Mar 28, 2005 | Issued |
Array
(
[id] => 4976805
[patent_doc_number] => 20070218036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Method For The Prevention Of Infection With Nodavirus And Method For The Treatment Thereof'
[patent_app_type] => utility
[patent_app_number] => 10/593762
[patent_app_country] => US
[patent_app_date] => 2005-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3154
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20070218036.pdf
[firstpage_image] =>[orig_patent_app_number] => 10593762
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/593762 | Method For The Prevention Of Infection With Nodavirus And Method For The Treatment Thereof | Mar 22, 2005 | Abandoned |